By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company bioMérieux S.A.

bioMérieux S.A. (BMXXY)

OTC Market Data in USD, Fundamentals in EUR
$14.62
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$17.24B
Market Cap
0.00
P/E Ratio (TTM)
0.67%
Forward Dividend Yield
$9.51 - $14.62
52 Week Range

BMXXY Stock Price Chart

Explore bioMérieux S.A. interactive price chart. Choose custom timeframes to analyze BMXXY price movements and trends.

BMXXY Company Profile

Discover essential business fundamentals and corporate details for bioMérieux S.A. (BMXXY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Specialties

IPO Date

9 Jun 2023

Employees

14.15K

CEO

Pierre Boulud

Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

BMXXY Financial Timeline

Browse a chronological timeline of bioMérieux S.A. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 Mar 2026

Upcoming earnings on 4 Sept 2025

Revenue estimate is $1.08B.

Dividend declared on 18 Mar 2025

A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 26 Jun 2025.

Earnings released on 7 Mar 2025

EPS came in at $1.89 , while revenue for the quarter reached $2.15B , beating expectations by +99.84%.

Earnings released on 30 Oct 2024

EPS came in at $1.95 , while revenue for the quarter reached $2.04B , beating expectations by +112.53%.

Dividend declared on 10 Jun 2024

A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 26 Jun 2024.

Earnings released on 23 May 2024

EPS came in at $1.81 , while revenue for the quarter reached $2.09B .

Earnings released on 30 Jun 2023

EPS came in at $1.49 , while revenue for the quarter reached $1.93B .

Dividend declared on 6 Jun 2023

A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 23 Jun 2023.

Earnings released on 31 Dec 2022

EPS came in at $2.04 , while revenue for the quarter reached $2.08B .

Earnings released on 30 Jun 2022

EPS came in at $2.01 , while revenue for the quarter reached $1.73B .

Earnings released on 31 Dec 2021

EPS came in at $3.08 , while revenue for the quarter reached $2.04B .

Earnings released on 30 Jun 2021

EPS came in at $2.77 , while revenue for the quarter reached $1.87B .

Earnings released on 31 Dec 2020

EPS came in at $2.39 , while revenue for the quarter reached $2.01B .

BMXXY Stock Performance

Access detailed BMXXY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run